Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty

Patients with clinically suspected central premature puberty undergo a GnRH stimulation test to have an appropriate diagnosis. 20 such girls will be recruited to this study and a modified GnRH stimulation test will be done. The modification includes prolonged blood sampling time (0, 30, 60, 90, 120, and 150 min after the GnRH injection instead of the usual 0, 30, 60, and 90 min). The girls will also be investigated twice. In randomised order they will be given either GnRH or placebo (isotone saline), on different days. One week to one month will separate the different investigation days.

The proteinase inhibitor 4-(2-aminoethyl) benzene-sulfonyl fluoride hydrochlorid (AEBSF) will be added to some of the blood tubes, and hydrochloric acid will be added to some of the plasma. All plasma samples will be frozen and all analyses will be done at the same time. Acylated ghrelin will be analyzed by Millipore's specific ELISA kit and deacylated ghrelin will be analyzed by Cayman's specific ELISA kit.

Anthropometric data as well as pubertal state will be collected. P-glucose, S-insulin, S-follicle stimulating hormone (FSH), S-luteinizing hormone (LH), and S-estradiol will also be analyzed.

Inclusion criteria

• Female gender.
• Clinical suspicion of central precocious puberty.
• A GnRH stimulation test is to be performed to make appropriate diagnosis.

Exclusion criteria

• Age < 1 year.
• Weight < 10 kg.
• Untreated hypo- or hyperthyroidism.
• Diabetes of any kind.
• BMI > 3 z-score.
• Growth hormone treatment.
• Syndrome or suspected syndrome.
• Tumour or congenital malformation of the hypothalamus or the pituitary gland. (Neuroradiology does not have to be performed only because of the study.)
• On going ulcus ventriculi or the patient has gone through surgery that removed part of the ventricle or changed it markedly in any other way.